T1	Participants 17 71	salbutamol-treated inpatients with acute bronchiolitis
T2	Participants 175 261	children admitted to the hospital with bronchiolitis treated with nebulized salbutamol
T3	Participants 384 875	The participants, children aged 6 weeks to 15 months, admitted with first-time wheezing, were eligible if their oxygen saturation was less than 95% on admission to the hospital and their Respiratory Distress Assessment Instrument (RDAI) score was greater than 6. Patients were excluded if they had any one of the following: an underlying disease that might affect cardiopulmonary status, asthma, recent treatment with steroids (within 2 weeks), or any history of adverse reaction to steroids
